Refine by
Cancer Cell Research Articles & Analysis
386 news found
RTsafe, a leading medical technology company specialising in quality assurance (QA) solutions for radiation therapy, and Icon Group (Icon), a leading integrated cancer care provider with a global reach across Australia, New Zealand, ASEAN, Mainland China and the United Kingdom, today announced the purchase of two RTsafe PRIME phantoms. These are the first PRIME phantoms to be installed in ...
ByRTsafe
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective ...
Breast cancer remains one of the most challenging diseases to treat, especially for aggressive forms such as triple-negative breast cancer. Researchers are working relentlessly to better understand tumor metabolism and to find new therapeutic strategies. Two recent studies highlight how critical glutamine metabolism is in breast ...
Creative BioMart, a biotechnology company focused on protein-related research solutions, has recently upgraded its epitope mapping service to better support researchers in therapeutic antibody development, vaccine design, and immunogenicity studies. The updated platform integrates multiple experimental approaches with customizable strategies, enabling more accurate identification of antibody ...
On March 16th, a team of dedicated runners, sponsored by Aquasystems – SFA enviro, took on the 100km Run Against Cancer in Belgium. Their goal? To raise awareness and funds for cancer research, a cause that touches so many lives worldwide. Like many companies, we at Aquasystems – SFA enviro have colleagues who have been confronted with this devastating ...
The results could guide individualized treatment for people with early-stage breast cancer in the future. “This collaboration with Weill Cornell Medicine contributes to our ongoing development initiatives in breast cancer research.," states Dr. ...
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, announced today that Tennessee Oncology, one of the United States’ largest community-based cancer care specialists that treats nearly half of Tennessee’s cancer patients across 35 clinics, has expanded its relationship with SOPHiA GENETICS to advance its cancer research. ...
In the rapidly evolving landscape of pharmaceutical innovations, CD Formulation emerges as a key player, offering customized drug conjugates services that cater to the rising demands for advanced drug development. Specializing in complex biologic formulations, Biologics & Biosimilars service team of CD Formulation is revolutionizing how drug conjugate products are conceptualized and produced, ...
In this piece, we talked to the two presenters of the poster “The Validation of a Homologous Recombination Deficiency Assay into Clinical Practice within the NHS”, Elizabeth Ratsma, Pre-Registration Clinical Scientist – Cancer Genomics and Charlotte Flanagan, PhD, Innovation Lead, from The Royal Marsden NHS Foundation Trust. The poster was recently presented at the ESMO ...
MSK-ACCESS® powered with SOPHiA DDM™ is a decentralized version of the highly validated liquid biopsy test developed by Memorial Sloan Kettering Cancer Center (MSK), a top cancer treatment and research institution. ...
SOPHiA GENETICS offers a comprehensive suite of liquid biopsy applications that have helped progress oncology research and tumor mutation profiling. Liquid biopsy testing offers an alternative to solid tumor testing by isolating cell-free DNA (cfDNA) from blood plasma, which may uncover circulating tumor DNA (ctDNA). ...
CD Genomics, a pioneering leader in genomic solutions, is proud to announce its cutting-edge whole genome sequencing (WGS) services. Utilizing the latest technologies from Illumina and PacBio platforms, CD Genomics offers precise and affordable sequencing solutions for a wide range of organisms, including viruses, microbes, plants, animals, and humans. Whole genome sequencing represents a ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, aims to enhance cell culture results by providing researchers and laboratories with a variety of simple and high-performance 3D cell culture systems. ...
Alfa Cytology, a premier contract research organization, recently launched its full-scale pancreatic cancer research services with robust platforms, powerful analytics, and cross-platform collaborations. ...
The International Agency for Research on Cancer reports that as recently as 2020, there were over 13,000 new cases of cancer in Puerto Rico. Tragically, there were also more than 5,500 deaths due to cancer in Puerto Rico that year alone. The American Association for Cancer Research has reported that more than 40% of all diagnosed cancers in the U.S. can be attributed to preventable causes. ...
The U.S. Department of Energy announced this week (Jan 24) that it will play a key role in the National Artificial Intelligence Research Resource (NAIRR) pilot as part of President Biden's push to ensure the United States is a leader in harnessing the promise and managing the risks of artificial intelligence (AI). This pilot, led by the U.S. National Science Foundation (NSF), aims to develop a ...
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its extensive portfolio of P53 and TP53 antibodies and solutions to support researchers in the critical field of cancer research. This comprehensive collection of research tools will empower scientists to advance their ...
Bone regeneration is one of the fastest growing research disciplines, given the massive impact it can have on the overall quality of life. ...
ByCELLINK
In turn, this empowers researchers to gain a deeper insight into the role of these markers in diverse cell types and biological processes. ...
This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge research in the fields of drug discovery, cancer research, and tissue engineering. ...
ByCELLINK